
Please try another search
Investing.com - HSBC has upgraded Divi's Laboratories Ltd (NS:DIVI) from Reduce to Buy, while significantly raising its price target to INR7,900.00 from INR5,020.00. The upgrade reflects HSBC's more...
On Sunday, Axis Capital (NYSE:AXS) Limited updated its assessment of Divi's Laboratories Ltd (DIVI:IN), increasing the price target to INR 6,430.00, up from the previous INR 6,100.00. The firm has...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review